Related Experiment Video
Updated: Apr 16, 2026
Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
Paediatric non-alcoholic fatty liver disease: an overview
1Department of Pediatric, Dammam University, Dammam, Saudi Arabia.
Insights
Non-alcoholic fatty liver disease (NAFLD) in children is a growing concern linked to obesity, increasing risks for liver and heart problems. Early detection and lifestyle changes are crucial for managing this progressive condition.
Area of Science:
- Pediatric Gastroenterology and Hepatology
- Public Health
- Cardiovascular Health
Background:
- Non-alcoholic fatty liver disease (NAFLD) is a spectrum of liver conditions, from simple steatosis to non-alcoholic steatohepatitis (NASH).
- Paediatric NAFLD is increasingly recognized as a global health issue, driven by rising childhood obesity rates.
- NAFLD in children is associated with increased risks of liver and non-liver related complications, including cardiovascular disease.
Purpose of the Study:
- To summarize current knowledge on paediatric NAFLD.
- To raise awareness among healthcare professionals about this under-recognized public health problem.
- To identify research gaps and suggest future research directions.
Main Methods:
- This is a review article.
- It synthesizes existing literature on NAFLD in children.
- It focuses on disease spectrum, associated risks, and current management strategies.
Main Results:
- Paediatric NAFLD, particularly NASH in obese children, can progress to liver fibrosis and failure.
- The disease is strongly linked to higher rates of hepatic and non-hepatic morbidities and mortalities compared to the general pediatric population.
- Cardiovascular disease association with NAFLD in children is a growing area of concern.
Conclusions:
- Paediatric NAFLD is a significant health issue requiring increased medical community awareness.
- Lifestyle modification, including diet and exercise for weight reduction, is the primary conservative treatment.
- Further research is needed to understand disease progression and identify at-risk individuals.
Abstract:
Non-alcoholic fatty liver disease (NAFLD) is a progressive disease that encompasses a spectrum of liver diseases, ranging from simple steatosis to non-alcoholic steatohepatitis (NASH). Data related to survival in children are scarce, but these data firmly associate NAFLD with higher risks of hepatic and non-hepatic morbidities and mortalities compared with the general population. More recently, the association between NAFLD and cardiovascular disease among children has increasingly been recognized. Given that obesity is a major risk factor for the disease, paediatric NAFLD is becoming a global issue, paralleling the dramatic rise in obesity worldwide. NASH, which is more common in obese children, has the potential to advance to liver fibrosis and failure. It is unclear why certain patients undergo such transformation but this susceptibility is likely related to an interaction between a genetically susceptible host and the surrounding environment. Currently, treatment is largely conservative and includes lifestyle modification, attainable through healthy weight reduction via diet and exercise. In this review, current knowledge about NAFLD in children is summarized. This review aims to increase the awareness of the medical community about a hidden public health issue and to identify current gaps in the literature while providing directions for future research.
Related Concept Videos
01:28Overview of Fatty Acid Metabolism
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
01:25Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
01:26Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...